PKU in adolescents: rationale and psychosocial factors in diet continuation
- PMID: 7766970
- DOI: 10.1111/j.1651-2227.1994.tb13463.x
PKU in adolescents: rationale and psychosocial factors in diet continuation
Abstract
Follow-up of early-treated children with PKU has shown that diet discontinuation in childhood presents risks of cognitive and emotional dysfunction in a substantial number of adolescents and young adults. This dysfunction includes IQ loss, mental processing abnormalities, learning difficulties, anxiety and personality disorders. In addition, neurologic deterioration has been reported in several such individuals. As a consequence of this current understanding of PKU, diet continuation, at least through adolescence and in the young adult years, is now recommended. Many centers are extending this to a policy of "diet for life". This represents a major challenge to adolescents and their families. Metabolic control using the criteria applied during childhood is virtually impossible to achieve past 12 years of age. Time constraints, social pressures, financial limitations and growing independence from the family combine to interfere with dietary control. Added to these difficulties are the biological changes during teenage years which reduce phenylalanine tolerance. To meet these challenges, we have identified a number of psychosocial factors that interfere with adherence to medical recommendations. The factors most highly related to metabolic control were social support for the diet and positive perceptions of treatment. This information has led to the development of support programs for adolescents and young adults with PKU.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Continuation vs discontinuation of low-phenylalanine diet in PKU adolescents.Eur J Pediatr. 1987;146 Suppl 1:A17-9. doi: 10.1007/BF00442050. Eur J Pediatr. 1987. PMID: 3691572 No abstract available.
-
Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.Orphanet J Rare Dis. 2015 Jun 18;10:80. doi: 10.1186/s13023-015-0294-x. Orphanet J Rare Dis. 2015. PMID: 26084935 Free PMC article.
-
Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up.Mol Genet Metab. 2019 Mar;126(3):246-249. doi: 10.1016/j.ymgme.2018.12.011. Epub 2018 Dec 26. Mol Genet Metab. 2019. PMID: 30598390
-
Outcomes beyond phenylalanine: an international perspective.Mol Genet Metab. 2010;99 Suppl 1:S79-85. doi: 10.1016/j.ymgme.2009.09.015. Mol Genet Metab. 2010. PMID: 20123476 Review.
-
[Phenylketonuria: a children's disease in adulthood].Ned Tijdschr Geneeskd. 2000 Jan 1;144(1):11-5. Ned Tijdschr Geneeskd. 2000. PMID: 10665298 Review. Dutch.
Cited by
-
Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study.Eur J Pediatr. 1996 Jul;155 Suppl 1:S39-44. doi: 10.1007/pl00014246. Eur J Pediatr. 1996. PMID: 8828607
-
Phenylketonuria patients' and their parents' knowledge and attitudes to the daily diet - multi-centre study.Nutr Metab (Lond). 2017 Aug 17;14:57. doi: 10.1186/s12986-017-0207-1. eCollection 2017. Nutr Metab (Lond). 2017. PMID: 28824701 Free PMC article.
-
Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia.Arch Dis Child. 2000 Mar;82(3):216-21. doi: 10.1136/adc.82.3.216. Arch Dis Child. 2000. PMID: 10685924 Free PMC article.
-
Public and private academic medical partnerships in improving nutritional management in phenylketonuria.Am J Public Health. 1997 Aug;87(8):1379. doi: 10.2105/ajph.87.8.1379. Am J Public Health. 1997. PMID: 9279281 Free PMC article. No abstract available.
-
Factors Impacting the Reduction in Neophobia Prevalence in Phenylketonuria Patients.Nutrients. 2024 Mar 7;16(6):768. doi: 10.3390/nu16060768. Nutrients. 2024. PMID: 38542680 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous